Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Dose-Intensive Chemotherapy in Locally Advanced STS
NCT00204646Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Feb 1999
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, ifosfamide, carboplatin, etoposide in soft tissue sarcoma (STS), sponsored by University Hospital Tübingen. Started Feb 1999; status: completed.
02
Drugs
doxorubicinifosfamidecarboplatinetoposide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00204646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204646.